Viral and Immunologic Factors Contributing to the Lack of HIV Transmission Among Couples in Rakai, Uganda
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00342160|
Recruitment Status : Completed
First Posted : June 21, 2006
Last Update Posted : April 24, 2019
This study will look at viral and immunologic factors involved in protecting against sexually transmitted HIV infection in couples in which one partner is infected and the other is not.
This study will include 50 couples who reside in Rakai, Uganda, and who have been together for at least 2 years. In some couples, both partners will be HIV-infected, in some couples only one partner will have HIV, and in some couples neither partner will have HIV.
Participants undergo the following procedures at each of four study visits:
- HIV counseling and testing
- Medical history, including questions about personal behaviors such as sexual practices and use of condoms
- Blood sample collection
- Urine sample collection
- Vaginal swab for women
Blood, urine and vaginal fluid samples are tested for HIV and other sexually transmitted diseases, such as syphilis. Blood and vaginal samples are also tested for HIV viral levels and immune response in HIV-infected individuals and for evidence of exposure to HIV in non-infected participants. Some blood is also tested for genetic markers to investigate whether certain proteins are related to resistance to HIV infection.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||88 participants|
|Official Title:||Virologic and Immunologic Factors Contributing to the Lack of HIV-1 Transmission in HIV-Discordant Couples in Rakai, Uganda|
|Study Start Date :||February 15, 2006|
|Study Completion Date :||November 13, 2012|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00342160
|Uganda Virus Research Institute|
|Principal Investigator:||Thomas C Quinn, M.D.||National Institute of Allergy and Infectious Diseases (NIAID)|